Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
367
datasets available to search
ShareScore release 0.9.0
Dataset results
367 results for “Ibrutinib”
Ofatumumab & Ibrutinib + Allogeneic Bone Marrow Transplant or Consolidation in High Risk Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT02388048. IPD Sharing: NO. Countries: 1. Publications: 0.
Glofitamab Plus Ibrutinib With Obinutuzumab for the Treatment of Patients With Mantle Cell Lymphoma, IGNITE MCL Trial
ClinicalTrials.gov study NCT06357676. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ibrutinib, Rituximab, Venetoclax, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
ClinicalTrials.gov study NCT03710772. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Observational Study of Ibrutinib Use in CLL
ClinicalTrials.gov study NCT03633045. IPD Sharing: NO. Countries: 1. Publications: 0.
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
ClinicalTrials.gov study NCT03128879. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Mavorixafor in Combination With Ibrutinib in Participants With Waldenstrom's Macroglobulinemia (WM) Whose Tumors Express Mutations in MYD88 and CXCR4
ClinicalTrials.gov study NCT04274738. IPD Sharing: UNDECIDED. Countries: 2. Publications: 0.
A Study to Evaluate Efficacy & Safety of Obinutuzumab, Ibrutinib, and Venetoclax in Richter's Syndrome;
ClinicalTrials.gov study NCT04939363. IPD Sharing: NO. Countries: 1. Publications: 0.
Post-Ibrutinib Colitis and Intestinal Microbiota
ClinicalTrials.gov study NCT03569137. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Avelumab, Utomilumab, Rituximab, Ibrutinib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma
ClinicalTrials.gov study NCT03440567. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lisocabtagene Maraleucel, Nivolumab and Ibrutinib for the Treatment of Richter's Transformation
ClinicalTrials.gov study NCT05672173. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Genetically Risk-Stratified Venetoclax, Ibrutinib, Rituximab (± Navitoclax) in Relapsed/Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT05864742. IPD Sharing: NO. Countries: 1. Publications: 0.
Ibrutinib in Steroid Refractory Autoimmune Hemolytic Anemia
ClinicalTrials.gov study NCT03827603. IPD Sharing: NO. Countries: 1. Publications: 0.
Ibrutinib Combined With Bendamustine and Rituximab in Newly Diagnosed Mantle Cell Lymphoma Patients Who Aged > 65 Years
ClinicalTrials.gov study NCT05406154. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines
GEO Series GSE102744. Homo sapiens. 8 samples. Type: Expression profiling by high throughput sequencing.
Longitudinal omics data followed by preclinical treatment studies identify proteasome inhibition as potential salvage strategy for ibrutinib-resistant CLL
GEO Series GSE215414. Mus musculus. 15 samples. Type: Expression profiling by high throughput sequencing.
Combination therapies of porcupine inhibition with ruxolitinib, ibrutinib or belumosudil in murine sclerodermatous GvHD
GEO Series GSE284107. Mus musculus. 15 samples. Type: Expression profiling by high throughput sequencing.
Dynamic molecular monitoring reveals that SWI/SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma
GEO Series GSE122513. Homo sapiens. 14 samples. Type: Expression profiling by high throughput sequencing; Genome binding/occupancy profiling by high throughput sequencing.
SUDHL4 cells treated with ibrutinib and/or miR-28 in vitro
GEO Series GSE229787. Homo sapiens. 8 samples. Type: Expression profiling by high throughput sequencing.
Ibrutinib-mediated atrial fibrillation
GEO Series GSE139427. Mus musculus. 10 samples. Type: Expression profiling by high throughput sequencing.
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells
GEO Series GSE106092. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.